Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

利司扑兰片 - NMPA Drug Approval Details

Approvals/NMPA/Unknown Drug

Approved

化学药品

Unknown Drug

Roche Pharma (Schweiz) AG🇨🇳 National Medical Products Administration

Approval Date: Aug 26, 2025
Approval ID: 8mOhhw4BZJr
Company: Roche Pharma (Schweiz) AG
Type: 化学药品

Approval Details

Approval Id: 8mOhhw4BZJr
Approval Number: 国药准字HJ20250103
Generic Name: 利司扑兰片
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 5mg
Reg Date: 2025-08-26
Expired Date: 2030-08-25
Company Name: Roche Pharma (Schweiz) AG
Production Company Name: F. Hoffmann-La Roche AG
Company Detail Path: /organization/roche-pharma-schweiz-ag
Production Company Detail Path: /organization/f-hoffmann-la-roche-ag

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 26, 2025

Approval ID

8mOhhw4BZJr

Type

化学药品

Back to NMPA Approvals